Hailey Tran
Essure is a permanent birth control implant for female sterilization. The device causes scar tissue to form in the fallopian tubes, blocking sperm and preventing pregnancy. Developed by Bayer, the procedure was popular due to its non-surgical nature and short implantation time. However, in 2018, Bayer announced it would discontinue sales and marketing of Essure in the US, citing financial reasons and concerns over side effects and complications. The device is no longer available in Australia either, with hospitals advised not to use it in any procedures. Women who have experienced issues are seeking support and removal procedures, which can be costly and complex. Given these developments, it is unlikely that hospitals still perform the Essure procedure, but some doctors may still have implants and perform the procedure in certain cases.
| Characteristics | Values |
|---|---|
| Essure Procedure | A birth control implant for non-surgical female sterilization |
| Essure Device | A soft flexible metal coil insert that causes scar tissue to form in the fallopian tubes |
| Composition | Polyester PET fibres, nickel, titanium, platinum, silver-tin and stainless steel |
| Side Effects | Perforation of the uterus and/or fallopian tubes, migration to the abdominal or pelvic cavity, persistent pain, suspected allergic or hypersensitivity reactions, chronic pelvic pain, hair loss, infections, excessive vaginal bleeding |
| Removal | Surgical procedure required; can be performed on an outpatient basis; costs range from $4,000 to $8,000 |
| Status | Discontinued by Bayer as of December 31, 2018; no longer sold or implanted in the US and Australia |
Explore related products
What You'll Learn
- Essure is a permanent birth control implant for non-surgical female sterilisation
- The procedure causes scar tissue to form in the fallopian tubes, blocking sperm and preventing pregnancy
- The device has been recalled in Australia and discontinued in the US as of 31 December 2018
- Removal of the device is challenging and costly, ranging from $4,000 to $8,000, and may require multiple surgeries
- Side effects of Essure include chronic pelvic pain, hair loss, infections, excessive bleeding, and allergic reactions
Essure is a permanent birth control implant for non-surgical female sterilisation
While Essure was once a popular form of permanent contraception, it has been discontinued in many countries due to reports of serious side effects and complications. Some women have experienced issues such as perforation of the uterus or fallopian tubes, migration of the device to other parts of the body, persistent pain, and suspected allergic or hypersensitivity reactions. There have also been cases of ectopic pregnancies among women with Essure implants. As a result of these concerns, Bayer, the manufacturer of Essure, voluntarily stopped selling and marketing the device in the US as of December 31, 2018.
Despite the discontinuation, some doctors and hospitals may still have supplies of Essure and can legally implant the device for up to a year after purchase. However, they are required to inform women of the potential risks before performing the procedure. The cost of the procedure can vary from $0 to $2,5000, and it may be covered by health insurance plans.
For women who have experienced complications or regret their decision to undergo Essure sterilisation, removal of the device can be challenging and may require multiple surgeries. The cost of removal can range from $4,000 to $8,000, and it is typically covered by insurance. While some women opt for a hysterectomy to remove the device, others may prefer to preserve their uterus and fallopian tubes through less invasive procedures.
Overall, while Essure was once a convenient and effective form of permanent birth control, the potential risks and complications have led to its discontinuation in many countries. Women considering Essure or experiencing issues with the device should carefully weigh the benefits and risks and seek medical advice.
Draining Fluid from Lungs: Hospital Procedure Explained
You may want to see also
Explore related products
The procedure causes scar tissue to form in the fallopian tubes, blocking sperm and preventing pregnancy
The Essure procedure is a birth control implant for non-surgical female sterilisation. The device causes scar tissue to form in the fallopian tubes, blocking sperm and preventing pregnancy. The scar tissue forms over three months following insertion, creating a barrier around the inserts to prevent pregnancy. After this period, women must undergo the Essure Confirmation Test, which uses a transvaginal ultrasound or vaginal X-ray to confirm the fallopian tubes are blocked.
The Essure device is made of polyester fibres, nickel, titanium, platinum, silver-tin, and stainless steel. It does not contain hormones, so women with the implant still get their period. The procedure takes around 36 minutes in a doctor's office and does not require cutting or anaesthesia. However, a local anaesthetic may be administered to reduce discomfort.
While Essure was once a popular form of permanent contraception, it has been discontinued in many countries due to reports of side effects and complications. In 2018, Bayer announced it would stop selling the device in the United States, and it was recalled in Australia in August 2017. Some women have reported serious side effects, including chronic pelvic pain, hair loss, infections, and excessive vaginal bleeding. There have also been reports of the device corroding and migrating inside the body, causing problems with the uterus and other organs.
Due to these concerns, hospitals and healthcare providers should inform women of the risks associated with Essure before implantation. The procedure is considered irreversible due to extensive scarring along a large portion of the fallopian tubes. However, some women who regret the procedure or experience side effects may consider Essure removal or reversal surgery. This surgery can be challenging due to the extensive scarring, and there is a risk of complications, including infection and organ damage.
Your Medical Records: Are They All in One Place?
You may want to see also
Explore related products
The device has been recalled in Australia and discontinued in the US as of 31 December 2018
Essure is a permanent birth control device for women (female sterilization) that was approved by the FDA in 2002. Conceptus and Bayer sold about 1 million devices worldwide between 2002 and 2018. However, the device has been linked to several adverse events, including perforation of the uterus and/or fallopian tubes, identification of inserts in the abdominal or pelvic cavity, persistent pain, and suspected allergic or hypersensitive reactions. There have also been reports of pregnancies, including ectopic pregnancies, among women who have undergone the Essure procedure. As a result, Bayer, the manufacturer of Essure, voluntarily stopped selling and distributing the device in the US as of December 31, 2018, citing declining sales. The company maintains that the decision was financial and that the device is safe and effective.
In Australia, Essure has been recalled, and the Therapeutic Goods Administration (TGA) has issued a hazard alert for the device. The TGA has received reports of serious adverse events associated with Essure, including device breakage and migration, organ perforation, and unwanted pregnancies. The recall affects all unused Essure devices in Australia, and healthcare professionals are instructed to return the devices to Bayer for disposal.
The discontinuation of Essure sales and distribution in the US and the recall in Australia have significant implications for patients and healthcare providers. Patients who have previously undergone the Essure procedure may experience complications and side effects, and may require surgical removal of the device. Healthcare providers should advise patients of the risks associated with Essure and monitor patients for any adverse events or product problems. Additionally, healthcare providers should report any adverse events or product problems to the relevant regulatory authorities to contribute to ongoing post-market surveillance studies.
The FDA and other regulatory bodies are committed to ensuring the safety and effectiveness of medical devices such as Essure. The FDA has extended the duration of the post-approval study for Essure from three years to five years to collect more data on long-term side effects and device removal. The agency is also requiring periodic blood testing of study patients to monitor inflammatory markers in response to claims of autoimmune disorders resulting from Essure implantation. These efforts will help to better understand the long-term safety profile of Essure and protect the health and well-being of patients.
Contacting Tata Memorial Hospital: A Step-by-Step Guide
You may want to see also
Explore related products
Removal of the device is challenging and costly, ranging from $4,000 to $8,000, and may require multiple surgeries
The Essure implant is a permanent birth control method for women. However, some women have chosen to have the device removed due to adverse side effects. The removal procedure can be challenging and costly, ranging from $4,000 to $8,000, with some sources citing higher prices. The cost is dependent on the severity of side effects and the type of surgery required. Most insurance plans should cover the removal procedure, but patients should verify this with their insurance provider.
The Essure implant is designed to cause scar tissue to form in the fallopian tubes, blocking sperm from reaching the egg and preventing pregnancy. However, this scar tissue can make the removal of the implant more difficult. Surgeons may use X-rays, ultrasounds, or scopes to locate the device before surgery. In some cases, a salpingotomy may be performed, which involves making a small cut in each fallopian tube to remove the Essure coils. A hysterectomy, or complete removal of the uterus, may also be necessary.
The removal procedure can range from a simple outpatient procedure to a more extensive surgery, such as a hysterectomy. The recovery time will depend on the technique used and how long the device was in the body. Outpatient procedures typically allow women to go home the same day, while a hysterectomy may require a longer recovery time of several weeks.
In some cases, multiple surgeries may be required to fully remove the Essure device. This could be due to the formation of scar tissue, the location of the device, or other complications. It is important for women considering Essure removal to find a specialist who has experience with the procedure and can advise on the best course of treatment.
The cost of Essure removal surgery can be a financial burden for many women, and it is important to consider all options and potential complications before undergoing the procedure.
Preventing Hospital Falls: Strategies for Patient Safety
You may want to see also
Side effects of Essure include chronic pelvic pain, hair loss, infections, excessive bleeding, and allergic reactions
Essure is a permanent female sterilization procedure that does not require surgery. It involves inserting a flexible metal coil into each fallopian tube through the vagina, cervix, and uterus. The coils are made of polyester fibres, nickel, titanium, platinum, silver-tin, and stainless steel. Scar tissue forms around the coils, blocking sperm from reaching the egg and preventing pregnancy.
While Essure has worked well for many women, thousands of others have reported adverse side effects and serious quality-of-life issues. The side effects of Essure include chronic pelvic pain, hair loss, infections, excessive bleeding, and allergic reactions. Some women have also experienced sexual dysfunction, incontinence, pelvic organ prolapse, nausea, chest pains, diarrhoea, vomiting, difficulty breathing, dizziness, blood clots, headaches, changes in weight, and fatigue. The most serious cases have even led to fatalities.
In response to these reports, the FDA has implemented several measures, including restricting sales of the device in 2018, requiring Bayer to add a black box warning to the labelling, and developing a black box warning to ensure women are aware of all the risks. In 2019, Essure was pulled from the American market, and Bayer discontinued sales and marketing of the device, citing financial reasons. However, the company maintains that Essure is safe and effective.
The removal of Essure can cost up to $8,000 and may require surgery, ranging from outpatient procedures to hysterectomies. The complexity of the removal depends on the severity of the side effects and the migration or breakage of the device.
Renting Hospital Rooms: Is It Possible?
You may want to see also
Frequently asked questions
Essure is a birth control implant for non-surgical female sterilization. The device causes scar tissue to form in the fallopian tubes, blocking sperm from reaching the egg and preventing pregnancy.
Bayer announced it would no longer sell the Essure device in the US after December 31, 2018, and it has been recalled in Australia. However, healthcare professionals could continue to implant the devices up to one year from the date they purchased them.
Some patients have experienced adverse events, including perforation of the uterus and/or fallopian tubes, identification of inserts in the abdominal or pelvic cavity, persistent pain, and suspected allergic or hypersensitive reactions. Other side effects include ectopic pregnancies, pelvic pain, hair loss, infections, and excessive vaginal bleeding.
The procedure could cost anywhere from $0 to $2,500 on average. Most health insurance plans covered the procedure in the past. Removal of the Essure device can cost between $4,000 to $8,000.
